High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease

Alimentary Pharmacology and Therapeutics

Volumn 18, Issue 4, 2003, Pages 443-449

  Ng, F H ^a   Wong, S Y ^a   Chang, C M ^a   Chen, W H ^b   Kng, C ^a   Lanas, A I ^c   Wong, B C Y ^b  

^a RUTTONJEE HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ADULT; AGED; ARTICLE; DRUG SAFETY; DYSPEPSIA; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INDIGESTION; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PEPTIC ULCER; PRIORITY JOURNAL; VOMITING;

AGED; ASPIRIN; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; LONGITUDINAL STUDIES; MALE; PEPTIC ULCER; PLATELET AGGREGATION INHIBITORS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TICLOPIDINE;

EID: 0042830369     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01693.x     Document Type: Article

References (20)

1. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81-106.
2. UK-TIA Study Group. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991; 54: 1044-54.
3. Silagy CA, NcNeil JJ, Donnan GA, Tonkin AM, Worsam B, Campion K. Adverse effects of low-dose aspirin in the healthy elderly population. Clin Pharmacol Ther 1993; 54: 84-9.
4. Gent M, Blakely JA, Easton JD, et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989; 1: 1215-20.
5. Hass WK, Easton JD, Adams HP, et al. A randomised trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989; 321: 501-7.
6. Gill S, Majundar S, Brown NE, Armstrong PW. Ticlopidine-associated pancytopenia: implications of an acetylsalicylic acid alternative. Can J Cardiol 1997; 13: 909-913.
7. CAPRIE Steering Committee. A randomized blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic event (CAPRIE). Lancet 1996; 348: 1329-39.
8. Ehsanullah RS, Page MC, Tildesley G, Wood JR. Prevention of gastroduodenal damage induced by non-steroidal antiinflammatory drugs: controlled trial of ranitidine. BMJ 1988; 297: 1017-21.
9. Wong BCY, Wong WM, Wang WH, et al. An evaluation of invasive and non-invasive tests for the diagnosis of Helicobacter pylori infection in Chinese - the most accurate tests for routine clinical use and research purposes. Aliment Pharmacol Ther 2001; 15: 505-12.
10. Yusuf S, Zhao F, Mehta ST, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. N Engl J Med 2001; 345: 494-502.
11. Sakaki N, Takemoto T. The relationship between endoscopic findings of gastric ulcer scar and ulcer relapse. J Clin Gastroenterol 1993; 17(Suppl. 1): S64-9.
12. Lanas AI. Current approaches to reducing gastrointestinal toxicity of low-dose aspirin. Am J Med 2001; 110(1A): 70S-73S.
13. Simon B, Elsner H, Muller P. Protective effect of omeprazole against low-dose acetylsalicylic acid. Endoscopic controlled double-blind study in healthy subjects. Arzneim-Forsch 1995; 45: 701-3.
14. Muller P, Fuchs W, Simon B. Studies on the protective effect of lansoprazole on human gastric mucosa against low-dose acetylsalicylic acid. An endoscopic controlled double-blind study. Arzneim-Forsch 1997; 47: 758-60.
15. Kitchingman GK, Prichard PJ, Daneshmend TK, Walt RP, Hawkey CJ. Enhanced gastric mucosal bleeding with doses of aspirin used for prophylaxis and its reduction by ranitidine. Br J Clin Pharmacol 1989; 28: 581-5.
16. Hawkey CJ, Somerville KW, Marshall S. Prophylaxis of aspirin-induced gastric mucosal bleeding with ranitidine. Aliment Pharmacol Ther 1988; 2: 245-52.
17. Lai KC, Lam SK, Chu KM, et al. Helicobacter pylori eradication compared with combined Helicobacter pylori eradication and lansoprazole in the prevention of recurrent ulcer complications associated with long term low-dose aspirin use. N Engl J Med 2002; 346(26): 2033-8.
18. Hawkey CJ, Karrasch JA, Szczepanski L, et al. Omeprazole compared with misoprostol for ulcers associated with non-steroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 1998; 338: 727-34.
19. Yeomans ND, Tulassay Z, Juhasz L, et al. A comparison of omeprazole with ranitidine for ulcers associated with non-steroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med 1998; 338: 719-26.
20. Lanza FL. A guideline for the treatment and prevention of NSAID-induced ulcers. Am J Gastroenterol 1998; 93: 2037-46.